e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Asthma: growing understanding of influential factors
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of high sensitivity C reactive protein in patients of bronchial asthma and its correlation with exacerbation rate and pulmonary function
B. Menon, C. Kaur, R. Kaushik, S. Pandita (New Delhi, India)
Source:
Annual Congress 2008 - Asthma: growing understanding of influential factors
Session:
Asthma: growing understanding of influential factors
Session type:
Thematic Poster Session
Number:
1145
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Menon, C. Kaur, R. Kaushik, S. Pandita (New Delhi, India). Evaluation of high sensitivity C reactive protein in patients of bronchial asthma and its correlation with exacerbation rate and pulmonary function. Eur Respir J 2008; 32: Suppl. 52, 1145
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function
Source: Annual Congress 2007 - Mechanisms of airway inflammation
Year: 2007
Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with high and low reversibility
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
Role of Pgp in corticosteroid sensitivity in patients with severe forms of bronchial asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008
Reduced heart rate variability in chronic bronchial asthma with steroid dependency
Source: Eur Respir J 2004; 24: Suppl. 48, 508s
Year: 2004
Increased airway resistance in asthma and emphysema and its relation to other pulmonary function tests
Source: Eur Respir J 2007; 30: Suppl. 51, 618s
Year: 2007
Correlation of bronchial inflammation pattern and airway response to cold stimulus in patients with uncontrolled asthma
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
Airway inflammation in COPD: physiological outcome measures and induced sputum
Source: Eur Respir J 2003; 21: 19S-28S
Year: 2003
Impact of bronchial airflow limitation and recent respiratory tract infection on the circulating level of C-reactive protein in an elderly population
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006
Serum interferon-gamma levels in chronic obstructive pulmonary disease and asthma patients: correlation with respiratory parameters
Source: Eur Respir J 2001; 18: Suppl. 33, 75s
Year: 2001
Low bronchial NO flux, but not low FENO, predicts pulmonary hypertension
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
High sensivity C reactive protein (HS-CRP) levels mark pulmonary and systemic inflammation in stable COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 337s
Year: 2006
Influence of N-acetylcystein in complex basic therapy on the dynamics of pulmonary function test indices in severe bronchial asthma patients
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008
Validity of serum surfactant protein D as a lung-specific biomarker in monitoring asthma, chronic obstructive pulmonary disease and chronic bronchitis in Lebanese patients: Preliminary results
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012
A study of the level of interleukin-32 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and asthma
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
The relationship between lung function and BAL return in severe asthma
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020
Fluctuations in airway function: chronic asthma seen as a complex dynamic system
Source: Annual Congress 2006 - Physiological year in review
Year: 2006
Correlations between exacerbation rate and blood eosinophil levels in COPD patients
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Clinical parameters predict the risk of acute exacerbation of COPD better than bronchial obstruction degree
Source: Eur Respir J 2001; 18: Suppl. 33, 210s
Year: 2001
On relationship between local and systemic chronic inflammation and between level of hypoxia and bronchial obstruction in COPD pts
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Expression of CD282+/CD284+ on blood granulocytes and its relationship to cytokine status in patients with stable chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept